From Early Discovery to Clinical Evaluation: Pharmacology Research & Perspectives Advances Drug Discovery

Last Updated: 30 April 2016

Darrell R. Abernethy, MD, PhD
Editor-in-Chief

Andrew Lawrence, PhD
Deputy Editor-in-Chief
Evaluation and publication of rigorous studies that support each stage of drug discovery and development are key to the mission of Pharmacology Research & Perspectives. After careful review, the papers in this virtual issue have been published in PR & P, and each provides useful and important understanding of the likelihood of success of “drugging” a potential drug target. This success is contingent on far more than a good idea, or a promising result from a molecular or cellular assay. In addition to those early discovery findings we publish studies in each step along the path to the realization of a drug that has efficacy for the treatment of human disease.
Brief Detailed

In Memoriam: Darrell R. Abernethy, M.D. Ph.D.

It is with deep sadness that the Editorial Team at PR&P must convey the news that Darrell Abernethy, Editor in Chief of the Journal, has recently passed away. Darrell has been instrumental in raising the profile and quality of PR&P in both his roles on the Journal, first as Deputy Editor and then Editor. He has been a true inspiration to so many of our authors and editors who work in the field of pharmacology, very much a team player, providing considered and thoughtful responses. His wise counsel will be missed.

Rest in peace

PR&P Editorial Team

Darrell's obituary can be viewed on the ASPET website